Dáil Éireann Debate, Tuesday - 3 November 2020
1364. Deputy Johnny Mythen asked the Minister for Health if his attention has been drawn to the shortage of supply of child flu vaccinations that have been ordered by pharmacists to be provided within primary school clinics in the south east; his plans to address this shortage; and if he will make a statement on the matter. [33366/20]
Amharc ar fhreagraThe Government has expanded the provision of seasonal influenza vaccination without charge to all of those in the HSE-defined at-risk groups, including healthcare workers, and to all children aged from 2 to 12 years. Vaccines are being administered via GPs and pharmacists, as in previous years.
This season, 1.95 million doses of influenza vaccine have been purchased, which is double the amount administered last season. The HSE has procured 1.35 million doses of the Quadrivalent Influenza Vaccine (QIV) for the forthcoming winter. This vaccine is being made available to all persons in an at-risk group and aged from 6 months up. In addition, the HSE has also purchased 600,000 doses of the Live Attenuated Influenza Vaccine (LAIV), which is delivered via nasal drops rather than by injection and is being made available to all children aged from 2 to 12 years old inclusive.
This expanded programme will ensure that those most vulnerable to the effects of influenza will have access without charges. This is in line with the advice of the National Immunisation Advisory Committee and represents a significant step forward in providing vaccination without charges.
Half of the total doses of LAIV (nasal) vaccination for administration to children aged from 2 to 12 years has been distributed to GPs and pharmacists. The LAIV vaccination programme for children is well underway across the country. A high uptake of the vaccine in children has been shown to reduce the spread of influenza in the community. Maximising uptake of LAIV in children will also help protect others against influenza in the community. The full quantity of LAIV ordered has now been received and is in the process of being distributed to GPs and pharmacists.
